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SURGICAL ASSESSMENT OF THE GERIATRIC ONCOLOGY PATIENT 
 
CY ANDREW LAMPUGNALE 
ABSTRACT 
Background  
The aging population in the United States will correlate with an increased number of 
cancer diagnoses as cancer is primarily a disease of the elderly. Providing this ever-
growing group of individuals with quality surgical management, while taking into 
account the unique needs and desires of this cohort, is a great challenge facing both 
geriatricians and surgeons going forward. The best approach to ensure that oncogeriatric 
patients receive the best tailored treatment is through the completion of a pre-surgical 
geriatric assessment. However, only a minority of oncogeriatric patients is undergoing a 
comprehensive pre-surgical geriatric assessment despite the majority of geriatricians and 
surgeons acknowledging its importance in order to properly risk stratify their patients.  
 
Literature review findings 
Multiple theories exist as to why geriatric assessments are not being utilized more 
frequently, but the most probable answer is that these assessments are very time-
consuming, making it virtually impossible for incorporation into a healthcare provider’s 
busy schedule. Comprehensive literature review regarding geriatric assessments amongst 
the oncogeriatric population found that the most sensitive and specific domains of the 
geriatric assessments predicting morbidity and mortality include Frailty Index, Social 
Support Survey, Mini-Nutritional Assessment, and Geriatric Depression Screening.  
		 vi 
Proposed Methods 
A novel educational intervention will be proposed to teach Physician Assistant and 
Medical Students about the domains of the geriatric assessment most predictive of post-
surgical risk during their surgical clerkship. The curriculum will utilize both simulation- 
and competency-based education training under the guidance of geriatricians and 
surgeons. Students will first learn the necessary skills in a controlled classroom 
environment and then proceed to incorporate these skills during their clerkship with 
patients on their service.  
 
Conclusions 
The goal of the proposed method is to instill the confidence and skills necessary to 
provide an accurate geriatric assessment for oncogeriatric patients in future clinicians. 
The field of geriatric oncology is going to grow exponentially in the up-coming years and 
familiarizing future clinicians with the most predictive domains regarding surgical 
outcome will improve treatment outcomes for oncogeriatric patients in the immediate and 
foreseeable future.  	  
		 vii 
TABLE OF CONTENTS 
 
TITLE……………………………………………………………………………………...i 
COPYRIGHT PAGE……………………………………………………………………...ii 
READER APPROVAL PAGE…………………………………………………………..iii 
ACKNOWLEDGMENTS ................................................................................................. iv	
ABSTRACT ........................................................................................................................ v	
TABLE OF CONTENTS .................................................................................................. vii	
LIST OF TABLES ............................................................................................................. ix	
LIST OF FIGURES ............................................................................................................ x	
LIST OF ABBREVIATIONS ............................................................................................ xi	
INTRODUCTION .............................................................................................................. 1	
Background ..................................................................................................................... 1	
Statement of the Problem ................................................................................................ 3	
Hypothesis....................................................................................................................... 3	
Objectives and specific aims ........................................................................................... 4	
REVIEW OF THE LITERATURE .................................................................................... 5	
Overview ......................................................................................................................... 5	
Existing research ........................................................................................................... 19	
METHODS ....................................................................................................................... 30	
		 viii 
Study design .................................................................................................................. 30	
Study population and sampling ..................................................................................... 30	
Recruitment ................................................................................................................... 30	
Data collection .............................................................................................................. 34	
Data analysis ................................................................................................................. 34	
Timeline and resources ................................................................................................. 35	
Institutional Review Board ........................................................................................... 35	
CONCLUSION ................................................................................................................. 36	
Discussion ..................................................................................................................... 36	
Summary ....................................................................................................................... 37	
Clinical and/or public health significance ..................................................................... 38	
APPENDIX A ................................................................................................................... 39	
APPENDIX B ................................................................................................................... 40	
APPENDIX C ................................................................................................................... 41	
APPENDIX D ................................................................................................................... 43	
APPENDIX E ................................................................................................................... 44	
LIST OF JOURNAL ABBREVIATIONS ....................................................................... 46	
REFERENCES ................................................................................................................. 48	
CURRICULUM VITAE ................................................................................................... 55	
 
  
		 ix 
LIST OF TABLES 
 
 
Table Title Page 
1 Population (in millions) of the United States, by age, in 
years 2000 and 2050 and the associated percentage 
change. 
 
6 
2 Population diagnosed with cancer at all ages and 
percentage of cases in population aged 65 and over by 
cancer type: 2003-2007 
 
9 
3 Patient and caregiver risk factors for depression in family 
caregivers 
 
18 
4 Predicting surgical outcomes in geriatric individuals using 
geriatric assessment 
 
20 
5 Preoperative frailty associated with increased 
postoperative risks  
 
23 
 
  
		 x 
LIST OF FIGURES 
 
 
 
Figure Title Page 
1 SEER Data Representing Percentage of New Cancer 
Cases of Any Site by Age Group and Not Adjusted for 
Sex or Race 
8 
 
 
  
		 xi 
LIST OF ABBREVIATIONS 
ACS NSQIP….American College of Surgeons National Surgical Quality Improvement Program 
ADLs……………………………………………………………Activities of Daily Living 
AGS…………………………………………………………....American Geriatric Society 
APA…………………………………………………American Psychological Association 
BFI…………………………………………………………………Brief Fatigue Inventory 
BMI………………………………………………………………… …...Body Mass Index 
BUSM……………………………………………..Boston University School of Medicine  
CC…………………………………………………………………….. Calf Circumference 
CGA………………………………………………...Comprehensive Geriatric Assessment 
CI………………………………………………………………………Confidence Interval 
ECOG………………………………………………Eastern Cooperative Oncology Group 
ESPEN………………………….European Society for Clinical Nutrition and Metabolism 
ESSO……………………………………………..European Society of Surgical Oncology 
FI…………………………………………………………………………… Frailty Index 
GA……………………………………………………………………Geriatric Assessment 
GDS…………………………………………………………..Geriatric Depression Screen 
HR…………………………………………………………………………….Hazard Ratio 
IADLs …………………………………………….Instrumental Activities of Daily Living 
ICU…………………………………………………………………….Intensive Care Unit 
MDT……………………………………………………………….Multidisciplinary Team 
MHI5 ……………………………………………………Five Item Mental Health Index 
		 xii 
MMSE…………………………………………………………...Mini Mental Status Exam 
MNA…………………………………………………………Mini Nutritional Assessment 
MNA-sf…………………………………………Mini Nutritional Assessment Short Form 
MOS-SSS………………………………Medical Outcome Study – Social Support Survey 
MS3…………………………………………………………...Third Year Medical Student 
MUST …………………………………………….Malnutrition Universal Screening Tool 
NRS 2002………………………………………………………Nutritional Risk Screening 
OR………………………………………………………………………………Odds Ratio 
PA……………………………………………………………………...Physician Assistant 
PA-SII …………………………………………..Second Year Physician Assistant Student 
PACE………………………………………Preoperative Assessment of Cancer in Elderly 
PREOP………………………….Preoperative Risk Estimation for Oncogeriatric Patients 
PS………………………………………………………………………Performance Status 
RR…………………………………………………………………………….Relative Risk 
SE……………………………………………………………………….......Standard Error 
SEER………………………………………...Surveillance Epidemiology and End Results 
SIOG…………………………………………International Society of Geriatric Oncology 
SOCS…………………………………………....Structured Observation of Clinical Skills 
SSO………………………………………………………….Society of Surgical Oncology 
TUG…………………………………………………………………..…Timed Up and Go 
UTI………………………………………………………………..Urinary Tract Infections
	1 
INTRODUCTION 
Background 
The maturation of the “Baby Boomer” generation has resulted in large changes in 
epidemiological trends. One notable trend is the significant increase in new cancer cases. 
Adults greater than 65 years old account for 60% of cancer incidence and 70% of cancer 
mortality,1 and from 1990-2013, there was a 35.6% absolute increase in cancer incidence 
attributed to aging.2 Also, the risk of developing cancer in individuals 65 years and older 
compared to their 55-64 year old counterparts is an increase of 2.9-fold for males and 
2.2-fold for females, thus solidifying that cancer is primarily a disease of the elderly.3 
However, despite surgery being largely accepted as the most effective cancer-ablative 
therapy and crucial aspect of the multi-modality treatment for many solid tumor types,4,5 
most surgeons express concern bringing their oncogeriatric patient to the operating 
room.6  
Western medicine is based on the principle of evidence based practice. At this 
time, clinicians are lacking the necessary evidence to assist in guiding their choice of 
surgical options for the oncogeriatric patient. Clinical evidence regarding the 
effectiveness of surgery in oncologic treatment applies mainly to the younger population 
and does not necessarily translate to the geriatric patient.4 The major challenge facing the 
surgical community when caring for the oncogeriatric population is sufficient evidence 
from prospective clinical trials as most oncology guidelines are typically based on data 
from trials where geriatric patients are absent or underrepresented.1,4 The data is 
especially weak for individuals 75 years and older.1 Lack of evidence makes surgical 
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oncologists more likely to deliver sub-optimal surgical management to their oncogeriatric 
patient compared to their younger cancer patients due to unfamiliarity and perceived 
limitations to conventional treatment.7 The lack of clinical evidence also forces surgeons 
to offer operative treatments based on the bias of ageism,8 despite multiple studies 
determining age alone is an unreliable selection criterion and cannot be used as the only 
measure to rule-out standard surgical management.9, 10 A demand clearly exists for 
improved geriatric representation in oncological clinical trials, however, this data 
resulting in improved treatment guidelines can take years to be finalized.  
Fit-for-surgery oncogeriatric patients have comparable outcomes to their younger 
counterparts.5 One-year after surgery, these oncogeriatric patients have the same cancer-
related survival compared to younger patients, and therefore, decreased survival in the 
elderly is attributed to mortality within one-year after surgery.11 With this alarmingly 
high rate of early mortality, different pre-operative geriatric assessment (GA) tools 
specific to the surgical geriatric population are being utilized. These include the 
Comprehensive Geriatric Assessment (CGA), Preoperative Assessment of Cancer in 
Elderly (PACE), and Brief Fatigue Inventory (BFI). These assessment tools are 
specifically designed to obtain a comprehensive picture in terms of health and 
functionality and optimize the treatment making process for surgical candidates to reduce 
influence of preference and prejudice.6, 12, 13 Therefore, with an increasing oncogeriatric 
population and the known heterogeneity of solid tumors within this population, the 
surgical community must utilize a practical preoperative assessment tool for their 
geriatric population in order to provide optimal and tailored treatment. Successful 
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implementation of a GA will assist surgical oncologists regarding the complex decision 
of surgical intervention for their oncogeriatric patients. 
 
Statement of the Problem 
Increasing numbers of geriatric patients are referred to surgical oncologists each year as 
the aging population has resulted in a significant increase in number of new cancer cases. 
However, treatment approaches between surgical oncologists for their oncogeriatric 
patient varies widely secondary to unfamiliarity and bias regarding outcomes in this 
population. The lack of continuity in surgical interventions is a great disservice to the 
geriatric population as most patients are not offered appropriate surgical management. 
Familiarity with the variety of preoperative assessment tools available to surgical 
oncologists for their oncogeriatric patient can assist in the decision making process and 
reduce discrepancies in surgical management of solid tumors. However, many GA’s are 
time-consuming and impractical which forces surgeons to continue their “rule-of-thumb” 
approach when offering treatment options to their patients despite evidence proving these 
pre-assessment tools can accurately predict post-operative complications and identify 
appropriate surgical intervention for this unique population.  
Hypothesis 
Administering a novel educational project to Medical and Physician Assistant students 
during their surgical clerkships teaching the most predictive aspects of the pre-surgical 
geriatric assessment for oncogeriatric patients will result in improved treatment plans and 
ensure a future of quality treatment for aging cancer patients.   
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Objectives and specific aims 
Implementation of a focused educational project led by geriatricians to teach surgical 
oncologists about only the clinically proven aspect of GA’s that predict increased risk of 
morbidity and mortality will allow greater acceptance of implementation amongst the 
surgical community. This will lead to improved risk stratification and surgical 
management of the geriatric oncology population. 	
1. Examine and gain appreciation for elderly cancer patients in terms of their unique 
characteristics, epidemiology, tumor biology, ethical differences, 
physiologic/sociologic vulnerabilities, and caregiver burden.  
2. Examine the components of the currently available pre-assessment tools, such as 
PACE and CGA, and through quantitative analysis determine the most relevant 
and predictive domains of post-operative complications. 
3. Develop a unique educational opportunity allowing surgeons and geriatricians to 
work together and share principles specific to their specialty and thus ensuring 
quality of care for the geriatric oncology population.  
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REVIEW OF THE LITERATURE 
Overview 
 
The elderly cohort 
Defining “elderly” is a controversial topic amongst the medical community and continues 
to be redefined in order to optimize care. The traditional demographic definition of 
“elderly” includes individuals greater than 65 years old.12 However, definition of an 
oncogeriatric patient requires universal agreement and specificity as the community age 
structure is very dynamic and age alone does not define this population.15 The 
oncogeriatric population is unique in the sense that no two individuals are equivalent and 
treatment options must be individualized based on patient expectation, presence of co-
morbidities, quality of life, etc.12 The heterogeneity amongst this population predicates 
the importance for preoperative assessment tools in order to individualize care.16 There 
are multiple GA’s at the disposal of both surgeons and geriatricians that identifies 
information such as physiologic reserve, that is routinely missed during history or 
physical examination.4 Improving the definition of oncogeriatric patients results in 
prolongation of life, prevention of geriatric syndromes, prevention of institutionalization, 
and improvement of subjective well-being.17 
Starting in the year 2011, the Baby Boom generation (individuals born from 
1946-1964) began to turn 65 years old. Now in the year 2016, the United States of 
America has already begun to experience the social and economic implication of this 
aging population. Census statistics regarding the percentage of the population aged 65 
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and older was 4.1% in 1900, 13.0% in 2010, and is projected to reach 20.9% by 2050.18 
Also, the population ages 65 and older is growing at a faster rate compared to the 
population less than 65 years old.18 By the year 2050, the 65 and older population is 
projected to reach a census of approximately 82 million, essentially doubling compared 
to 2012 (Table 1).19 This disproportionate growth, known as “population aging,” is 
relevant for the surgical oncology community since cancer is well-known as a “disease of 
the elderly” and the medical community will experience an associated proportionate 
growth in cancer diagnosis. The International Agency for Research on Cancer predicts an 
increase from 12.4 million to 26 million new cancer cases from 2008 to 2030 with 
majority of these cases in the population 65 years of age and older.20,21  
Table 1: Population (in millions) of the United States, by age, in years 2000 and 2050 
and the associated percentage change. 
Age Year 2000 Year 2050 Percentage 
Change 
Total 275,306 403,687 46.6% 
16-64 177,974 236,602 32.9% 
65+ 34,835 81,999 135.4% 
85+ 4312 19,352 379.8% 
Adapted from Wiener et al. (2002)19 
A specific challenge facing the elderly population, as well as the medical 
community, is the attitude of ageism. The American Psychological Association (APA) in 
2005 defined ageism as a “prejudice towards, stereotyping of and/or discrimination 
against any person or persons directly and solely as a function of their having attained a 
chronological age which the social group defines as old.”12 Unfortunately, surgeons are 
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no exception to this ageist bias, and studies have found that age alone can dictate 
treatment strategies despite the availability of many other assessment tools that risk 
stratify patients much more effectively.8 The ingrained ageism amongst the surgical 
community results in a wide array of recommended treatment options to the oncogeriatric 
patient. More widespread use of GA’s for oncogeriatric patients will help diminish the 
impact of ageism and promote standard of care regarding surgical management of the 
oncogeriatric patient.  
 
Cancer epidemiology in the elderly 
The increase in median life expectancy is coupled with an increase in cancer diagnoses 
secondary to the well-documented association between aging and incidence of cancer. 
This large demographic shift is going to result in an epidemiological “time bomb” due to 
the increased number of oncology cases for which the medical community is not 
prepared. One glaring weakness facing the medical community is the lack of evidence-
based oncology guidelines for proper treatment of oncogeriatric patients. According to 
Surveillance Epidemiology and End Results (SEER) data, cancer of any site is most 
frequently diagnosed among people aged 65-74 (Figure 1).22 58% of cancers and 69% of 
cancer deaths affect individuals 65 years and older and over the next 30 years, the 
prevalence of malignancy in old age is expected to rise by nearly one-third. 23 According 
to the United States Census Data from 2010, cancer was the second leading cause of 
death for the population aged 65 and over, accounting for 396,173 deaths, and this 
remained relatively stable with data from 2009.18 This epidemiological data implies a 
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profound impact on the medical community and mandates improved treatment guidelines 
for oncogeriatric surgical candidates. 
Figure 1: SEER Data Representing Percentage of New Cancer Cases of Any Site by Age 
Group and Not Adjusted for Sex or Race.  
 
SEER Stat Fact Sheets22 
 
Similar to all age groups, the incidence and survival rates of different cancers occurs with 
varying frequencies in the oncogeriatric population. Data from the United States Census 
Bureau lists the most common cancers in the 65 and older cohort as cancers of the 
digestive system, male genital system, and female breast (Table 2).18 Also, the proportion 
of cancer survivors continues to increase which can be attributed to improved knowledge 
regarding biology/pathophysiology as well as better treatment regimens. Five-year 
survival rates have significantly increased over the past few decades and reached 69% for 
all cancers between 1999-2005.18 Prostate and breast cancer may have the highest 
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incidence of disease, but they also have the highest five-year survival rates with both 
reaching 90% and above.18 However, despite steady improvements in five-year survival 
rates, there remains room-for-improvement. The oncogeriatric surgical patient likely 
experiences decreased long-term survival compared to their younger counterpart due to 
early mortality, and improvement in geriatric assessment tools can address this glaring 
issue. 11 
Table 2: Population diagnosed with cancer at all ages and percentage of cases in 
population aged 65 and over by cancer type: 2003-2007 
Cancer 
Type 
Population 
with cancer 
Percentage 
65 and over 
Percentage 
65-74 
Percentage 
75-84 
Percentage 
85 and over 
All cancers 1,717,500 54.2 24.7 21.8 7.7 
Digestive 
systems 
322,348 62.1 24.5 26.2 11.4 
Male genital 
system 
270,179 58.2 33.9 19.9 4.4 
Breast (Female) 249,658 40.9 19.5 15.8 5.6 
Respiratory 
system 
243,951 67.1 31.0 28.3 7.8 
Colon and 
rectum 
177,307 63.4 24.4 26.8 12.2 
Urinary system 132,680 63.5 26.1 27.3 10.1 
Female genital 
system 
97,835 40.2 19.2 15.1 5.9 
Lymphoma 83,668 49.8 20.4 21.4 8.0 
Skin 82,475 42.3 17.8 17.8 6.7 
Leukemia 45,780 53.3 19.8 22.9 10.6 
Adapted from West et al. (2014)18 
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Tumor biology of cancer and aging 
The biology of cancer and aging is a complex question and multiple hypothesis regarding 
fundamental biological interactions have been proposed. However, evidence exists 
supporting that older cancer patients contain age-and-tumor-related biological differences 
rendering them unique. Age-related factors contributing to the unique tumor biology 
includes decreased immune surveillance, increased susceptibility of cells to carcinogens, 
increased duration of carcinogenic exposure, oncogene activation, decreased DNA repair, 
as well as deficiencies in tumor-suppressor genes.12 Significant evidence exists that for 
several solid tumors (most notably breast, prostate, and lung solid tumor cancers) the 
biology varies in different age cohorts with deviations in growth patterns and doubling 
times, DNA ploidy, p53 expression, tumor angiogenesis, intrinsic hormonal receptor 
expression, extracellular matrix expression, and percentage of cells in S-phase.3 The age-
related and tumor-related factors also work synergistically to reveal the biological 
diversity with age. For example, the microenvironment of aging tissue is not compatible 
for rapid tumor growth and thus tumors that are histologically identical amongst any 
demographic will behave inherently different in the oncogeriatric patient.24 Lack of 
evidence remains regarding the subcellular changes involved in the aging process and 
cancer susceptibility and further research in this field can revolutionize oncogeriatric 
treatment guidelines.25 
 Work-up and treatment must be approached differently from the perspective of 
the healthcare provider as age influences histological type, cancer site, and site 
migration.3,12 Tumors in the elderly population have a higher frequency of an indolent 
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histology and thus an overall more favorable tumor profile.12 The elderly population is 
also more likely to experience higher incidence of right-sided colonic cancer, well-
differentiated gastric tumors, low-grade lobular or mucinous type breast cancer, and 
adenocarcinoma of the distal esophagus.26 These anatomical and histological distinctions 
result in somewhat age specific signs and symptoms at presentation and must be 
considered during surgical evaluation and screening. Also, positive information for the 
geriatric cohort, age itself does not act as an independent negative prognostic variable for 
cancer free survival for multiple cancer types, including: colorectal, gastric, esophageal, 
liver, head and neck, and breast cancer.12  
 The elderly population faces an additional obstacle regarding their cancer care 
which is substandard staging prior to treatment. Multitude of epidemiological data 
indicate that the elderly receive less extensive preoperative treatment and diagnostic 
investigations resulting in diagnosis at more advanced stages with a 3-fold increase in 
stage III disease in patients 80 years old.3, 27 Also, amongst the oncogeriatric population, 
there is a larger proportion of cases with unknown tumor stage and cancers that are 
histologically or cytologically non-confirmed.9 The unique biology and pathophysiology 
of the oncogeriatric patient makes staging more challenging and results in suboptimal 
surgical treatment opportunities for these patients. 
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Addition of geriatric principles in clinical trials 
One of the major challenges facing healthcare providers when caring for their 
oncogeriatric patients is the lack of data from prospective clinical trials on this cohort, 
especially in individuals age 75 and older.1 Currently, the evidence-based oncology 
guidelines are derived from clinical trials where adults are underrepresented and trial 
members are typically younger than the median age of diagnosis for the disease.28 The 
lack of data regarding treatment guidelines for the oncogeriatric patient is becoming 
increasingly alarming due to the rapid growth of the aging population in the United States 
of America. The intersecting of cancer and aging provides the medical community the 
unique ability for collaboration between geriatricians and oncologists to transform cancer 
treatment to state-of-the-art evidence based care. 
 There has been significant discussion regarding the potential reasons 
oncogeriatric patients have disproportionate low rates of enrollment. Most of the 
proposed reasons are based on misconceptions held by clinicians and healthcare proxies 
that geriatric patients are unable to tolerate or benefit from treatment in clinical trials, 
especially common solid tumor trials, despite a lack of data supporting this misconceived 
belief.28 Both clinicians and families assume that older patients are less likely to benefit 
or tolerate experimental treatments and thus should be considered ineligible. One survey 
found that 50% of American oncologists deem their patient’s ineligible for clinical trials 
due to age alone, despite 80% of the same oncologists agreeing that patients receive 
better treatment when enrolled in clinical trials.29 On the contrary, the 
underrepresentation of geriatric patients due to stringent eligibility criteria are important 
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safeguards to prevent treatment-associated morbidity and mortality. Many elderly 
individuals are deemed ineligible for clinical trials due to organ impairment and 
coexisting medical conditions as these co-morbid conditions can increase risk of 
treatment-related toxicity, unjustly impact results of the trial, and place the individual at 
greater risk.28,29,30 Unfortunately, these strict eligibility guidelines prevents enrollment for 
geriatric patients with normal age-related organ impairment or co-morbid conditions that 
will not interact with treatment and thus ultimately could potentially benefit from 
enrollment in the clinical trial.31 Thankfully, this problem of underrepresentation has 
slowly been changing across the oncologic medical community and many recent trials are 
being congratulated for recruiting trial populations with mean ages over 65 years old. 
 The addition of elderly adults in to Phase II clinical trials is critical for the 
formation of future cancer treatment guidelines as age-related physiological changes will 
impact the pharmacokinetics and pharmacodynamics of the treatment.31 During a Phase II 
clinical trial, the treatment is administered to a larger group of individuals with the main 
goals of the trial to monitor safety and efficacy on a larger scale. With enrollment of 
elderly adults in these Phase II trials, the efficacy of the treatment can be measured 
against age-related physiological changes and lead to future interventions that minimize 
risk and maximize efficacy.28,31 Additional data from these trials allows healthcare 
providers the ability to offer the best tailored treatment for the oncogeriatric patients. 
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Ethical considerations 
The field of geriatrics requires special ethical considerations for every case. All 
physicians, not just geriatricians, must remain cognizant of the unique issues faced by 
these patients and approach each case with an open-mind to work as a collaboration with 
the patient. Over the past several years, oncologists and geriatricians have worked 
alongside one another to assimilate geriatric principles into oncology treatment in an 
attempt to improve decision-making by estimating life expectancy, identifying 
vulnerabilities, and addressing patient preference.32 For example, one study found that 
90% of elderly adults would elect against low-burden/life-saving treatment if that 
treatment had the potential to lead to severe functional or cognitive impairment.33 Also, 
while respecting autonomy, physicians must be capable of evaluating the patient’s ability 
to make treatment decisions regarding health care and incorporate family and social 
services when a situation dictates.34 Many unique challenges face providers of the 
geriatric population but there remains a strong desire across the medical community to 
develop common ground regarding their care. 
 Older individuals are more likely to experience complex health and social needs 
beyond their primary cancer diagnosis/pathology. These concerns must be considered 
during evaluation as these additional health and social needs can negatively impact 
treatment tolerance and necessitate the need for modified therapy.35 It has been 
demonstrated that geriatric patients are at risk for poorer outcomes if they have more 
complex social needs as their treatment decisions are typically focused on the cancer 
pathology and not factors such as frailty, comorbidity, and social situation.36 Due to the 
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complexity of the oncogeriatric patient, they are excellent candidates for a 
multidisciplinary team (MDT) approach regarding their treatment. The MDT approach 
allows clinicians to focus on one aspect of the treatment process and optimize the unique 
skills from multiple different medical and social specialties. Making MDT therapy 
standard for oncogeriatric patients allows meetings and discussions amongst healthcare 
providers regarding treatment decisions to proceed in a predictable fashion, expedite 
decision-making, and allow discussion extending beyond just cancer pathology.35 
 One of the most complex and challenging decisions for both healthcare providers 
and patients is the decision to withdraw or withhold life-sustaining interventions. This 
decision directly translates to the oncogeriatric patient as surgery remains the best 
available curative option for many solid tumors. The ethical principle of autonomy 
underlies the right to refuse, or discontinue, undesired medical/surgical interventions as 
well as the right to decline intervention on previously consented-to procedures.37 
However, many providers are hesitant to withdrawal life-saving or life-sustaining 
interventions due to fear of litigation or prosecution of unlawful death despite this choice 
being the patients ethical and legal right.37 It is imperative to ensure that patients who 
refuse or request discontinuation of life-sustaining treatment have capacity to make these 
decisions. Also, end-of-life values and goals should be addressed early in the treatment 
stage while patients possess decision making capacity.38 Overall, clinicians must 
acknowledge and respect all patient’s autonomy and surgeons must be flexible in their 
management and tailor surgical options with respect to a patient’s goals.  
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Caregiver burden for oncogeriatric patients 
The field of geriatric oncology is rapidly growing and these patients have significant 
caregiving requirements. Much of the day-to-day care of all elderly individuals is 
performed by friends and family who are frequently referred to as “informal caregivers,” 
and up to 63% of homecare for oncogeriatric patients is provided by these informal 
caregivers.39 The caregivers can be further classified as “vulnerable” or “non-vulnerable” 
with the distinction being vulnerable caregivers have limitations secondary to their own 
poor health or serious health conditions.40 The healthcare community needs the number 
of informal caregivers to parallel the increasing numbers of oncogeriatric patients. 
However, caregiving is associated with a significant physical, emotional, and financial 
toll that cannot be overlooked since caregiver burden results in worse outcomes for the 
patient. Geriatric assessments can assist clinicians early in the treatment course identify 
oncogeriatric patients requiring greater-than-usual caregiving demands and allow for 
referral to the appropriate resource so both patient and caregiver can obtain the support 
needed.41 
 Oncology patients of all ages require assistance performing physical activities, but 
these needs are amplified in the geriatric oncology population. The activities for which 
oncogeriatric patients require assistance are wide ranging, but up to 43% of patients 
require assistance with IADLS and ASLS just to maintain independence.40 These 
physical needs are typically performed by informal caregivers; moreover, the median age 
of these caregivers is 63 years old and vulnerable caregivers are more commonly 
performing activities of daily living (ADLs) and IADLs than non-vulnerable 
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caregivers.39,40 Caregivers assisting with physical activities have reported significant 
physical toll with 32% of vulnerable and 15% of non-vulnerable caregivers reporting that 
their health was negatively impacted by caring for the patient.40 Also, 56% of spousal 
caregivers reported “caregiving strain” which was correlated with a 63% increase 4-year 
mortality risk for the caregiver.42 These significant physical demands on caregivers must 
be considered by all clinicians, and better screening modalities must to be utilized to ease 
the burden. 
 The emotional and financial toll placed on the caregiver is frequently overlooked 
by the healthcare system. Family caregivers are more commonly depressed. 
Approximately 67% of family caregivers are depressed and 35% have severe depression 
when screened with the Beck Depression Inventory.43 Distinct caregiver and patient risk 
factors have been associated with higher risks of depression in caregivers (Table 3).43,44 
The financial toll of caring for an oncogeriatric patient can be staggering and most 
families are unable to cover all expenditures. Many families face major financial 
repercussions including 62% of families depleted their family savings, 13% delayed their 
own health care, and 27% changed education plans.43 Also, 48% of families lost a large 
source of income as family caregivers are more likely to miss work with 69% missing 
work secondary to caregiving responsibilities.43,45 All of these unique issues must be 
taken into consideration by clinicians when treatment options are presented to patients 
and their caregivers.   
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Table 3: Patient and caregiver risk factors for depression in family caregivers 
Patient Characteristics Caregiver Characteristics 
• Symptomatic 
• Requires around-the-clock 
assistance with ADLs and IADLs. 
• ECOG PS of 3 or 4 
• Female 
• Vulnerable caregiver 
• Poor adaptation skills 
• Being the patient’s spouse 
• Burdened 
Data from Rhee et al. (2008)43 
 
Educational opportunities 
Due to burgeoning interest in the field of geriatric oncology, multiple organizations, such 
as SIOG, have developed dedicated courses, conferences, and meetings with clear 
objectives to target management of this population.3 These conferences and courses 
typically do not highlight surgical management of the oncogeriatric patient, but instead 
focus on medical oncology.3 However, substantial interest in the surgical management of 
oncogeriatric patients exists as evidenced by the 118% increase in surgical papers 
focused on the geriatric oncology population from 1982-1986 compared to 1997-2002.3 
The lack of surgical focus in current education opportunities coupled with significant 
interest in surgical management of oncogeriatric patients presents an opportunity to 
implement an educational intervention for both geriatricians and surgeons and thus 
further advancing this unique specialty. 
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Existing research 
Research has been completed regarding risk assessment and the perioperative 
management of the geriatric surgical oncology patient. Systematic review published in 
the Journal of Clinical Oncology in 2014 outlined the importance of geriatric assessment 
tools in predicting surgical outcomes (Table 4),4 but only 6.4% of surgeons use CGA in 
daily practice and only 36.3% collaborate with geriatricians.46 With the multitude of 
significant data from these multiple trials and systematic reviews, the American Geriatric 
Society (AGS) in collaboration with the American College of Surgeons National Surgical 
Quality Improvement Program (ACS NSQIP) completed a structured literature review on 
PubMed to identify meta-analyses, clinical trials, systematic reviews, and practice 
guidelines from 1/1/1990 to 12/31/2011 to create optimal pre-operative assessment of the 
geriatric surgical patient.4,14 However, these best practice guidelines did not solely focus 
on the oncologic geriatric surgical population. Despite significant overlap between non-
oncologic and oncologic geriatric surgical patients, it is imperative for the medical 
community to recognize the subtleties of the geriatric oncology population and address 
these unique needs. Also, by addressing the domains of CGA found to significantly 
confer increased risk of morbidity and mortality, more surgeons will implement these 
geriatric domains into their practice resulting in improved patient care. 
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Table 4: Predicting surgical outcomes in geriatric individuals using geriatric assessment 	
Reference Age 
(years) 
No. of 
Patients 
Type of Surgery Predictor Outcome 
Robinson et 
al 
68-80 110 Elective Surgery requiring 
postoperative ICU 
admission 
Impaired cognition, 
recent falls, lower 
albumin, greater 
anemia, functional 
dependence, and 
increased 
comorbidities 
6-month 
postoperative 
mortality and post-
discharge 
institutionalization. 
Robinson et 
al 
67-79 186 Elective surgery requiring 
postoperative ICU 
admission 
Cognitive 
impairment 
Increased 
postoperative 
complications, 
length of stay, and 
long-term 
mortality. 
Preoperative 
Assessment 
of Cancer in 
the Elderly 
(PACE) 
³70 460 Cancer surgery for solid 
tumors 
Disability, fatigue, 
and abnormal 
performance status. 
Postoperative 
complications. 
Dale et al 80% 
were 
older 
than 60 
76 Pancreaticodudodenectomy 
for pancreatic tumors 
Fried’s exhaustion Major 
complications, 
longer hospital 
stay, and ICU 
admissions 
Large et al ³65 49 Radical cystectomy for 
bladder cancer 
Cognitive 
impairment and 
older age 
Postcystectomy 
delirium 
Fukuse et al 60-84 120 Thoracic surgery, multiple 
causes 
Functional 
dependency and 
cognitive 
impairment 
Postoperative 
complications 
Makary et al 65-94 594 Multiple surgeries Frailty Postoperative 
complications, 
length of stay, and 
discharge to skilled 
nursing or assisted 
living facility 
Kim et al ³65 141 Multiple surgeries Functional 
dependency, poor 
nutrition, and 
cumulative 
impairment in 
geriatric assessment 
In-hospital death, 
post-discharge 
institutionalization, 
adverse in-hospital 
events, and 
prolonged length 
of stay 
Revenig et al 19-86 189 Oncologic, urologic, and 
general surgery procedures 
Intermediately frail 
or frail on the 
Hopkins Frailty 
Score 
30-day 
postoperative 
complications 
Huisman et 
al 
Older 
than 70 
180 Elective surgery for solid 
tumors 
Timed Up & Go test 30-day 
postoperative 
complications 
Abbreviation: ICU, intensive care unit 
 
Adapted from Korc-Grodzicki et al. (2014)4 
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Frailty 
One of the most common themes regarding assessment of the oncogeriatric patient is the 
absolute necessity of frailty assessment for all patients. Many papers discuss the 
importance that all oncogeriatric practices address frailty, and evaluation/documentation 
of frailty syndrome is recommended for best practice guidelines using the Frailty Index 
(FI) (Table 5).4,14,47 According to the American College of Surgeons and American 
Geriatric Society, frailty is a syndrome of decreased physiologic reserve and resistance to 
stressors leaving the patient with increased vulnerability to poor health outcomes such as 
worsening mobility, disability, falls, hospitalizations, and even death.14 The prevalence of 
frailty increases with age, but a systematic review by Handforth et. al published in 2014 
found the prevalence within the oncogeriatric population is significantly higher and 
estimated at 42%.48 Many different studies have been performed to develop and 
operationalize a phenotype of frailty. The most revolutionary study was published in 
2001 when Fried et al. completed a study using data from the Cardiovascular Health 
Study which was a prospective, observational study of men and women 65 years and 
older.47 Fried et al. performed baseline evaluations for frailty using the FI (Appendix A) 
and then followed the cohort with annual examinations and surveillance for outcomes of 
hospitalization, disability, falls, incident disease, and mortality. The outcomes of their 
study reported a prevalence of frailty at 6.9%, increased with age, and greater in women 
than men. Also, a statistically significant association exists between frailty and African 
Americans, lower socio-economic status, and having higher rates of comorbid chronic 
disease and disability. Intermediate frail patients contained increased risk of 
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postoperative complications and 2-fold increased risk of becoming frail over 3 years 
compared to non-frail patients.47 The revolutionary aspect of this study is that frailty is 
now defined as a physiologic syndrome and a clinically distinct entity from comorbidity 
and disability and provided standardized screening for frailty and risk of frailty in older 
adults. 
For the surgical community, the major drawback from the study by Fried et al. 
was that their population did not solely consist of elderly surgical patients and thus 
surgeons had to be cautious extrapolating the results to the surgical community. 
However, Makary et al. validated these results for elderly surgical patients with their 
prospective study of surgical patients ages 65 and older presenting to Johns Hopkins 
Hospital for elective surgery from July 1, 2005, to July 1, 2006.49 The results from this 
prospective study found pre-operative frailty to be associated with increased risk for post-
operative complications, increased length of stay, and discharge to a skilled or assisted-
living facility after previously living independently at home (Table 5).49 The results from 
this study reveal the importance of widespread use of the FI to assist with clinical 
decisions regarding surgical treatment approaches for the geriatric oncology population. 
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Table 5: Preoperative frailty associated with increased postoperative risks  
Complication Frailty Assessment Odds Ratio 95% Confidence 
Interval 
Increased risk for 
post-op 
complications 
Intermediate 2.06 1.18-3.60 
Frail 2.54 1.12-5.77 
Increased risk for 
longer length of 
stay 
Intermediate 1.49 1.24-1.80 
Frail 1.69 1.28-2.23 
Discharge to skilled 
or assisted-living 
facility 
Intermediate 3.16 1.0-9.99 
Frail 20.48 5.54-75.68 
Adapted from Makary et al.(2010)49 
 
Functional status 
The functional status of an oncogeriatric patient is an essential element of the geriatric 
assessment and can be measured in numerous ways including ADL’s/IADL’s or Timed 
Up and Go (TUG) assessment. However, a web-based survey sent to members of 
European Society of Surgical Oncology (ESSO) and Society of Surgical Oncology (SSO) 
found only a minority of surgeons perform functional assessments including 8% 
measuring ADL/IADL’s and 8% performing TUG.46 Even though many surgeons are not 
using functional status to assess their patients, the importance was validated with the 
international prospective study published in 2008 that found a dependent IADL was the 
most important independent predictor of any post-surgical complications (RR 1.43, 95% 
CI 1.03-1.98) while disability assessed by ADL’s (RR 2.01, 95% CI of 1.37-2.93) or 
IADL’s (RR 1.58, 95% CI of 1.11-2.24) was associated with longer hospital stay greater 
than cancer specific median.6 These results translate to a 50% increased likelihood of 
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post-surgical complications with a dependent IADL6 and therefore must be a component 
of all pre-operative geriatric assessment.  
Functional status is routinely assessed by the presence of mobility impairments 
through TUG or the 10-item physical function index of the Medical Outcomes Study 
Short Form-36.5 These different tests measures mobility, coordination, and muscle 
strength. An international multicenter cohort study investigated screening tools for 
Preoperative Risk Estimation for Oncogeriatric Patients (PREOP) regarding 30-day 
postoperative outcomes and the multivariate analysis found TUG (OR 3.1, 95% CI 1.1-
8.6) was a significant predictor outcome of major complications such as wound or 
respiratory compliations.50 This study supports the research that mobility can accurately 
address morbidity and mortality, however, a conflicting study found that use of a walking 
aid, physical inactivity, or gait speed slower than 1m/s over 4 meters were not predictive 
of all-cause mortality.51,52 These conflicting results can largely be attributed to the 
heterogeneity of these assessments as functional status measurements thus making it 
difficult to compare results.  
 
Nutritional status 
The prevalence of nutritional status impairment amongst the geriatric oncology 
population ranges from 32-45.5%.5 Risk factors for impaired nutritional status amongst 
all oncology patients include decreased performance status, intra-abdominal tumors, as 
well as advanced disease and age, but the geriatric oncology cohort contain independent 
psychological, social, and economic risk factors such as depression, ADL/IADL 
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impairments, insufficient recourses, and poor dentition.53, 54 Multiple validated screening 
tools exist to select individuals at increased nutritional risk. These include Nutritional 
Risk Screening (NRS 2002), Mini Nutritional Assessment (MNA) (Appendix B)55 or 
MNA short form (MNA-sf), and the Malnutrition Universal Screening Tool (MUST). A 
systematic comprehensive review of six databases published in 2012 found nutritional 
status was assessed in 54% of studies with MNA, thus making this the most frequently 
utilized assessment tool for nutritional status.5,56 According to the European Society for 
Clinical Nutrition and Metabolism (ESPEN), surgical patients should be classified as 
severe nutritional risk if they exhibit BMI<18.5kg/m2, serum albumin <3.0g/dL (with no 
evidence of renal or hepatic dysfunction), and unintentional weight loss >10-15% within 
6 months and thus necessitate full nutritional assessment.5,14 
 Many different studies have researched the relationship between nutritional status 
and adverse post-operative outcomes in the geriatric oncology population. Results from a 
prospective clinical study assessing nutritional status as a potential risk factor for adverse 
post-operative outcome following abdominal cancer surgery found that weight loss ³10% 
(OR 6.51, 95% CI 1.43-29.76) and increased risk according to MNA were statistically 
significant predictors for discharge to non-home institutions as well as short-term 
mortality.58 This data was consistent when compared to the systematic review of studies 
published in English or French from May 1997 to May 2012 in order to assess the CGA 
domains most predictive of cancer-specific outcomes.59 This systematic review 
established that nutritional status with hazard ration of 1.84-2.54 was one of the multiple 
domains reported for predicting mortality in both surgical and non-surgical oncogeriatric 
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patients.59 The post-operative adverse events for which individuals with poor nutritional 
status are at increased risk include wound complications (dehiscence and anastomotic 
leaks), infectious complications (pneumonia, UTI’s, surgical site infections), and 
increased length of stay.14  
 
Social Support 
All cancer patients immensely benefit from the presence of a dependable support groups, 
however, this is amplified in oncogeriatric patients due to the high demand of caregiver 
assistance to maintain any resemblance of independence. However, the evidence 
regarding the use of social support assessments as a part of the pre-operative assessment 
tool for the oncogeriatric patients is limited.5 A prospective longitudinal study evaluated 
geriatric assessment domains in relation to clinically important outcomes in 660 geriatric 
breast cancer survivors.60 Social support was measured by the Medical Outcome Study – 
Social Support Survey (MOS-SSS) (Appendix C)61 score and women with poor treatment 
tolerance compared with women with good treatment tolerance had clinically significant 
lower MOS-SSS scores (64.02 [SE = 3.1] v 76.64 [SE =1.8], respectively; p = .0004) and 
‘inadequate finances’ was found to be an independent predictor for a higher 7-year 
mortality risk.60 Despite the lack of research regarding the effect of social support on the 
outcomes of the oncogeriatric patient, many clinicians agree that the lack of social 
support will result in poorer outcomes. The varying reasons for poorer outcomes include 
prolonged hospital stays, discharge to non-home institutions, and difficulty completing 
care due to lack of transportation. Addressing a patient’s social support at an initial 
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referral allows clinicians to intervene at an early stage of the process and improve 
morbidity and mortality.  
 
Cognitive Impairment and Depression 
Cognitive impairment and depression frequently go unrecognized in the elderly 
population but have significant impact on morbidity and mortality. The cross-sectional 
study published in The Journal of Nutrition Health and Aging in 2016 studied the 
presence of cognitive impairment in individuals ³75 years old using the Mini Mental 
Status Examination (MMSE) found that 16% of individuals had cognitive function 
suggestive of dementia with 89% of whom not previously diagnosed.62 Cognition is 
considered an important part of the geriatric assessment and is a separate, and stand-alone 
domain. The most commonly used, and most commonly studied, measurement of 
cognition with the GA is the MMSE.5 However, varying results regarding the 
effectiveness of MMSE to predict post-operative morbidity and mortality in the 
oncogeriatric population have been published. Prospective observational pilot cohort 
study found individuals 65 years and older with lower MMSE scores were significantly 
associated with developing post-cystectomy delirium and thus more likely to face re-
operation or re-admission.52 In comparison, the prospective PACE Study published by 
the SIOG surgical task force in February 2008 found no association with abnormal 
MMSE (<24) with increased risk of 30 day morbidity (RR 1.23, 95% CI 0.81-1.88), 
prolonged hospital stay greater than cancer specific median (RR 1.18, 95% CI 0.76-1.86), 
or thirty day mortality.6 However, the PACE study contained limitations in regard to 
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evaluation of the MMSE. Selection bias most likely played a role in the results as all 
patients were excluded if they had a baseline MMSE of less than 18 and therefore the 
population of the study does not accurately represent the entire geriatric oncology 
population. Obtaining a detailed history and completing a MMSE must still be highly 
recommended as pre-existing cognitive impairment has been known to strongly predict 
post-operative delirium and associated with worse surgical outcomes in the non-
oncologic geriatric population.14 
 It is widely agreed amongst clinicians that emotional status, most commonly 
depression, has a profound impact on mortality and post-operative complications for 
oncogeriatric patients. The most common assessment of mood as part of the GA is the 
Geriatric Depression Screen (GDS) with the short version being  a 15-item Yes/No 
questionnaire (Appendix D).63,64 This is the most commonly used tool as it was 
specifically designed and validated for the elderly population.5 Ramjaun et al. reported in 
their systematic review published in 2013 that depression was one of the geriatric 
domains predictive of mortality with a hazard ratio of 1.51-1.81.59 Also, the study of 660 
geriatric breast cancer survivors published by Clough-Gorr et al. reported that a score of 
less than 80 (indicative of depression) on the five-item Mental Health Index (MHI5) was 
one of the four GA domains predictive of significantly increased 7-year mortality 
(HR=1.34, 95% CI 1.01-1.85).60 Finally, multi-variable regression published by Giantin 
et al. in the Journal of Geriatric Oncology discovered significant increase in 6 and 12 
months mortality for individuals with a positive GDS score.65 These studies highlight the 
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importance of performing depression screening on all oncogeriatric patients as both 
immediate and long-term mortality are negatively impacted by depressive symptoms. 	  
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METHODS 
Study design 
This study will be a simulation based classroom training transitioning to competency 
based hospital training targeted to better improve Medical and Physician Assistant (PA) 
students’ knowledge and skills in managing patients amongst the surgical geriatric 
oncology community. 
Study population and sampling 
Subjects will be recruited during their surgery clerkships and will consist of third year 
Medical Students (MS3’s) as well as second year Physician Assistant students (PA-SII’s) 
from Boston University School of Medicine (BUSM). MS3’s and PA-SII’s will complete 
this additional training during their surgery clerkships and the student cohort will 
typically consist of 20-25 MS3’s and 2-4 PA-SII’s. Initially, students will be recruited 
strictly from Boston Medical Center. There is potential to expand the intervention to 
BUSM students completing surgical clerkships in different sites throughout New 
England. 
Recruitment 
BUSM Medical and PA students completing their surgical clerkships will be recruited for 
the study. An entire cohort of students during their surgical clerkship will be recruited to 
the experimental group. Students in the experimental group will be recruited to complete 
the classroom based simulation training that then transitions to the competency based 
hospital training. The control group will consist of the entire cohort of students 
completing their surgical clerkship following the experimental group. The control group 
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will not complete the classroom based simulation but instead will start immediately with 
the competency based hospital training. At the end of the month and following collection 
of data, the students in the control group will complete the same classroom based 
simulation the control group received.  
Aims 
• Students will demonstrate competency and understanding of geriatric assessment 
for oncogeriatric patients by geriatricians during simulation based classroom 
training. 
• Students will demonstrate ability to manage and assess oncogeriatric patients by 
surgical preceptors during competency based training. 
Learning objectives 
At the end of the session, the learner will be able to… 
1. Interpret frailty using the Frailty Index (Appendix A) and translate this 
designation to surgical risk. 
2. Interpret functional status by evaluating ability to perform ADL’s/IADL’s and 
evaluate post-surgical complications. 
3. Interpret nutritional status using the MNA (Appendix B) and translate this 
designation to surgical risk. 
4. Interpret social support using the MOS-SSS (Appendix C) and will consult 
additional resources for their patients if results indicate. 
5. Interpret cognitive impairment and depression using the MMSE and GDS 
(Appendix D), respectively, and translate these results to surgical risk. 
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6. Interpret their effectiveness regarding ability to adequately assess oncogeriatric 
patients from their surgical clerkship preceptors through Student Observation of 
Clinical Skills (SOCS) card (Appendix E). 
 
Intervention 
Surgical clerkship students assigned to the experimental group will be asked to complete 
a classroom based simulation training facilitated by geriatricians recruited from Boston 
Medical Center. Ideally, the classroom based simulation training will be completed the 
first Friday of the surgical clerkship. Students will be excused from floor/operating 
room/clinic duties following morning rounds to complete the training. The simulation 
date will be an agreed upon date by the geriatricians completing the training along with 
surgical preceptors. The classroom based simulation will begin with a PowerPoint 
presentation by the geriatrician faculty member outlining the unique characteristics and 
the multiple tools available to clinicians to evaluate the surgical risk for the oncogeriatric 
patients. The following topics will be addressed during the PowerPoint presentation: 
• Epidemiological and physiological distinction of oncogeriatric patients. 
• Currently available evidence-based oncology guidelines and the challenge of 
treating oncogeriatric patients due to lack of evidence from prospective clinical 
trials. 
• Ethical considerations and importance of caregiver burden when offering surgical 
treatment approaches for oncogeriatric patients. 
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• Evidence supporting the use of the Frailty Index (Appendix A), Mini Nutritional 
Assessment (Appendix B), MOS-SSS (Appendix C), and Geriatric Depression 
Scale: Short Form (Appendix D) in assessing fit-for-surgery oncogeriatric 
patients. 
Students will form pairs following completion of the PowerPoint presentation. Two 
vignettes will be provided to each pair. Each vignettes will illustrate a geriatric patient 
meeting with a surgical oncologist to discuss their surgical treatment options following a 
solid tumor diagnosis. Students will take turns portraying the geriatric patient while their 
counterpart plays the role of a MS3 or PA-SII. The role of the MS3 or PA-SII includes 
interviewing the patient and completing the different pre-surgical assessment tools 
outlined in the PowerPoint and formulating a treatment plan for the patient including 
categorizing if the patient is fit-for-surgery. Geriatricians facilitating the classroom 
training will circle the room observing, intervening when applicable, and answer 
questions. 
 Students in both the control and experimental group will proceed to the simulation 
based training following completion of the classroom based training. All students will be 
expected to interview a minimum of one oncogeriatric patient with a solid tumor 
diagnosis in clinic during their surgical clerkship. Students will evaluate and stratify the 
patient using the Frailty Index, Mini Nutritional Assessment, MOS-SSS, and Geriatric 
Depression Scale: Short Form as taught during the classroom based training. Students 
will then present the patient with specific recommendations to their surgical preceptors 
citing specific trials and case studies to support their treatment decision. Students will 
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provide their surgical preceptors a SOCS card (Appendix E) which preceptors will use to 
assess the student’s ability to properly evaluate an oncogeriatric patient. A minimum 
score of 18 out of 24 is required order to pass the simulation based training and a score of 
less than 18 must be remediated. The SOCS card will be turned in to the surgical 
clerkship director at the end of the rotation and used for data collection to determine the 
effectiveness of the intervention. 
Data collection 
Data will be collected from the SOCS card completed by all surgical preceptors grading 
the students’ ability to complete geriatric surgical assessment for an oncogeriatric patient. 
Students who fail the competency based training must remediate this portion, however, 
their scores will only be counted from their first attempt. The remediation is completed 
for the student’s growth as a future clinician. 
Data analysis 
Data from the SOCS card will be analyzed using a student t-test with an µ=.05 to assess 
BUSM Medical and PA students’ ability to incorporate specific domains of the geriatric 
assessment in their pre-surgical assessment of an oncogeriatric patient depending if they 
received simulation based training (experimental) vs. no simulation based training 
(control). The SOCS card for the experimental group will also be analyzed for mean item 
scores with standard deviation in order to help guide changes to the simulation based 
training curriculum. 
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Timeline and resources 
Summer 2016 • IRB submission and approval 
• Recruitment of geriatrician faculty at Boston Medical Center 
to complete the simulation based classroom training. 
 
Fall 2016 
 
• Development of PowerPoint alongside geriatrician for 
simulation based classroom training. 
• Development of vignettes. 
• Advise surgical clerkship preceptors about the addition of the 
new educational intervention. 
Spring 2017 
through Spring 
2018 
• MS3’s and PA-SII’s complete simulation based classroom 
training and competency based hospital training. 
• Collect SOCS cards. 
• Study completion 
Summer 2018 • Data analysis. 
• Manuscript to be submitted for peer-review.  
 
Institutional Review Board 
The study protocol will be submitted to the IRB of Boston University Medical Campus 
for exemption due to educational studies criteria under 45 CFR 46. 101 (b). A full IRB 
protocol will be submitted for expedited review if the exempt status is not approved. 
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CONCLUSION 
Discussion 
Developing a clerkship curriculum is a daunting task for all parties involved. Most 
clerkships are only four to six weeks in length with an over-arching goal to expose 
students to enough cases and hospital experience to accurately depict the specialty as well 
as promoting growth as a clinician. The addition of the described simulation-and-
competency based training in the surgical clerkship has the potential to significantly 
improve MS3’s and PA-SII’s medical education as well as patient care, but potential 
limitations exist which can make the educational intervention challenging. First, not all 
surgical clerkships are identical from student to student, and thus it will be likely more 
challenging for some students to have the opportunity to interview and complete the 
simulation based training. Also, surgical preceptors are not receiving any additional 
education regarding this education intervention, and thus scoring on the SOCS cards can 
vary amongst preceptors and not be an accurate depiction of the students ability. In 
addition, all of the students in the study will be recruited from the same university 
(BUSM) which is located in a major metropolitan city. Many of the potential 
oncogeriatric patients are likely to contain other social determinants regarding their care 
not addressed with the geriatric assessment. Regardless, this educational intervention is 
anticipated to be successful with significantly higher SOCS card scores with the 
experimental group compared to the control group despite these potential limitations. 
 The findings from this study are going to be largely generalizable to other medical 
schools across the country and can be easily implemented with a similar adjustment to the 
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surgical clerkship curriculum. Some medical schools may face challenges implementing 
this educational intervention as they might not have the same surplus of clinicians and 
patients available as Boston Medical Center, but the teaching of the important aspects of 
pre-surgical geriatric assessment tools will easily translate. 	
Summary 
The significant increase in oncogeriatric surgical cases presents a major problem to the 
medical community in the very near future. The challenge facing the medical community 
regarding the oncogeriatric population is not only one of insufficient resources, but also 
one of inadequate evidence based practice guidelines for surgical oncology treatment of 
solid tumors in the elderly. The fields of gerontology and surgical oncology need more 
geriatric patients in Phase II clinical trials in order to refine the current recommended 
treatment guidelines, however, this data can take decades to accumulate and analyzed 
prior to refinement of guidelines. Therefore, clinicians must begin utilizing pre-surgical 
assessment tools in order to guide surgical treatment. Analysis of the multiple aspects of 
currently available pre-surgical geriatric assessment tools has resulted in the formation of 
the four most predictive aspects of morbidity and mortality in an oncogeriatric patient 
and can help tailor treatment options. Many clinicians may be hesitant to implement even 
the shortened pre-surgical geriatric assessment outlined including the Frailty Index, 
MNA, MOS-SSS, and GDS but these tools can be completed by medical assistants, 
students, or even the patient with little to no training and not result in any additional time 
to the clinician’s schedule. The proposed addition to the surgical clerkship curriculum for 
MS3’s and PAS-II’s of simulation based classroom training transitioning to competency 
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based hospital training will train future clinicians and allow them to gain appreciation for 
the importance of the multiple different aspects of end of life care.  	
Clinical and/or public health significance 
The geriatric population is an expanding community with distinct characteristics 
requiring tailored treatment plans. Future medical doctors and PA’s will have the 
responsibility of treating geriatric patients, and since cancer is universally known as a 
disease of the elderly, will inevitably treat many individuals among the oncogeriatric 
cohort. Thus, despite which field of specialty future healthcare providers pursue, all must 
attain baseline knowledge regarding the assessment of oncogeriatric patients in order to 
practice the most effective evidence-based medicine. The best place for medical 
providers to receive this knowledge is during their medical education since multiple 
resources are at the disposal of the institution to provide the proposed classroom and 
hospital training from this intervention. Education of all future healthcare providers, and 
not just surgical oncologists and geriatricians, is most practically achievable during 
medical school and will create more well-rounded medical doctors and PA’s. 
 This intervention also targets the integration of two distinct medical specialties: 
gerontology and surgical oncology. The students which complete this intervention will 
become exposed to the important truth that medical specialties do not exist in a vacuum, 
but instead are interwoven and the ability of different specialists to function together 
results in improved outcomes for the patient. The opportunity for students to experience 
and participate in combining principles from two different specialties will be an 
invaluable tool with future training and separate BUSM students.  
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APPENDIX A 
Frailty Index (Operational Definition) 
Criteria Definition 
Shrinkage Unintentional weight loss ³10 pounds past 
year 
Weakness Decreased grip strength 
Exhaustion Self-reported poor energy and endurance 
Low physical activity Low weekly energy expenditure 
Slowness Slow walking 
The patient receives 1 point for each criterion met: 0-1, not frail; 2-3, intermediate frail 
(pre-frail); 4-5, frail. 
Adapted from Chow et al. (2012)14 
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APPENDIX B 
Mini Nutritional Assessment 
Sex: _____ Age: _____ Weight, kg: _____ Height, cm: _____ Date: _____  
Screening 
A. Has Food intake declined over the past 3 months due to loss of appetite, digestive 
problems, chewing or swallowing difficulties? 
• 0 = severe decrease in food intake  
• 1 = moderate decrease in food intake  
• 2 = no decrease in food intake 
B. Weight loss during the past 3 months 
• 0 = weight loss greater than 3 kg (6.6 lbs) 
• 1 = does not know 
• 2 = weight loss between 1 and 3 kg (2.2-6.6 lbs) 
• 3 = no weight loss 
C. Mobility 
• 0 = bed or chair bound 
• 1 = able to get out of bed/chair but does not go out 
• 2 = goes out 
D. Has suffered psychological stress or acute disease in the past 3 months? 
• 0 = yes 
• 2 = no 
E. Neuropsychological problems 
• 0 = severe dementia or depression 
• 1 = mild dementia 
• 2 = no psychological problems 
      F1. Body Mass Index (BMI) (weight in kg)/ height in m)2 
• 0 = BMI less than 19 
• 1 = BMI 19 to less than 21 
• 2 = BMI 21 to less than 23 
• 3 = BMI 23 or greater 
IF BMI IS NOT AVAILABLE, REPLACE QUESTION F1 WITH QUESTION F2. DO 
NOT ANSWER QUESTION F2 IF QUESTION F1 IS ALREADY COMPLETED. 
      F2. Calf circumference (CC) in cm) 
• 0 = CC less than 21 
• 3 = CC 31 or greater 
Screening Score 
(Maximum of 14 points) 
• 12-14 points = Normal nutritional status 
• 8-11 points = At risk of malnutrition 
• 0-7 points = Malnourished 
Adapted from Nestle Nutrition Institute55 
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APPENDIX C 
MOS-SSS Instrument 
 
 
People sometimes look to others for companionship, assistance, or other types of support. How 
often is each of the following kinds of support available to you if you need it? Choose one 
number from each line 
Emotional/Informational 
Support 
None of the 
time  
A little of 
the time 
Some of 
the time 
Most of 
the time 
All of the 
time 
Someone you can count on 
to listen to you when you 
need to talk 
     
Someone to give you 
information to help you 
understand a situation 
     
Someone to give you good 
advice about a crisis 
 
     
Someone to confide in or 
talk to about yourself or 
your problems 
     
Someone whose advice 
you really want 
     
Someone to share your 
most private worries and 
fears with 
     
Someone to turn to for 
suggestions about how to 
deal with a personal 
problem 
     
Someone who understands 
your problems 
     
Tangible Support None of the 
time  
A little of 
the time 
Some of 
the time 
Most of 
the time 
All of the 
time 
Someone to help you if 
you were confined to bed 
     
Someone to take you to the 
doctor if you needed it 
     
Someone to prepare your 
meals if you were unable 
to do it yourself 
     
Someone to help with daily 
chores if you were sick 
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Affectionate Support None of the 
time  
A little of 
the time 
Some of 
the time 
Most of 
the time 
All of the 
time 
Someone who shows you 
love and affection 
     
Someone to love and make 
you feel wanted 
     
Someone who hugs you      
Positive social Interaction None of the 
time  
A little of 
the time 
Some of 
the time 
Most of 
the time 
All of the 
time 
Someone to have a good 
time with 
     
Someone to get together 
with for relaxation 
     
Someone to do something 
enjoyable with 
     
Additional Item None of the 
time  
A little of 
the time 
Some of 
the time 
Most of 
the time 
All of the 
time 
Someone to do things with 
to help you get your mind 
off things 
     
How to Score the Survey: 
• To obtain a score for each subscale, calculate the average of the scores for each item in 
the subscale. 
• To obtain an overall support index, calculate the average of (1) the scores for all 18 
items included in the four subscales, and (2) the score for the one additional item (see 
last item in the survey). 
Adapted from Rand Health61  		 	
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APPENDIX D 
Geriatric Depression Scale: Short Form64 
Question Yes No 
Are you basically satisfied with your life?  X 
Have you dropped many of your activities and interests? X  
Do you feel that your life is empty? X  
Do you often get bored? X  
Are you in good spirits most of the time?  X 
Are you afraid that something bad is going to happen to you? X  
Do you feel happy most of the time?  X 
Do you often feel helpless? X  
Do you prefer to stay at home, rather than going out and doing new 
things? 
X  
Do you feel you have more problems with memory than most? X  
Do you think it is wonderful to be alive now?  X 
Do you feel full of energy?  X 
Do you feel that your situation is hopeless? X  
Do you think that most people are better off than you are? X  
- Answers in bold X indicate depression and score 1 for each bolded answer. 
- Score >5 is suggestive of depression and should warrant follow-up comprehensive 
assessment. 
- Score ³10 is almost always indicative of depression 
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APPENDIX E 
Structured Observation of Clinical Skills 
Department of Medicine – BUSM 
Observed Competency: Pre-Surgical Assessment of an Oncogeriatric Patient 
 
Date: _________________________ 
Name of Student: _________________________ 
Name of Observer: _________________________ 
Level of Observer: PGY     1     2     3     Fellow     Attending 
 
The purpose of this SOCS is to provide feedback to the student on the systematic 
performance of the pre-surgical assessment of an oncogeriatric patient. 
 
Frailty 
o 0 = Did Not Assess  
o 1 = Minimal understanding of the FI and does not accurately score patient in any 
of the criteria  
o 2 = Partial mastery of the FI and accurately scores patient in some of the criteria  
o 3 = Proficient mastery of the FI and accurately scores in patient in all criteria and 
accurately categorizes patients as not frail, intermediate frail, or frail  
o 4 = Exceeds expectation of the FI by accurately scoring patient in all criteria and 
categorization and applies results to surgical risk assessment  
Functional Status 
o 0 = Did Not Assess  
o 1 = Minimal understanding of ADL’s/IADL’s and does not accurately evaluate 
patient  
o 2 = Partial mastery of ADL’s/IADL’s but does not accurately identify patients 
with dependent IADL’s  
o 3 = Proficient mastery of ADL’s/IADL’s and accurately identifies patients with 
dependent IADL’s  
o 4= Exceeds expectations in evaluation of functional status assessing 
ADL’s/IADL’s and applies results to surgical risk assessment  
Nutrition 
o 0 = Did Not Assess  
o 1 = Minimal Understanding of the MNA and does not accurately score patient in 
any of the criteria  
o 2 = Partial mastery of the MNA and accurately scores patient in some, but not all, 
of the criteria  
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o 3 = Proficient mastery of the MNA and accurately scores in patient in all criteria 
and accurately categories as normal nutritional status, at risk of malnutrition, or 
malnourished  
o 4 = Exceeds expectation of the MNA by accurately scoring patient in all criteria 
and categorization and applies results to surgical risk assessment  
Social Support 
o 0 = Did Not Assess 
o 1 = Minimal understanding of the MOS-SSS and does not accurately evaluate 
patient 
o 2 = Partial mastery of the MOS-SSS but does not accurately identify patients 
requiring increased social support 
o 3 = Proficient mastery of the MOS-SSS and accurately identifies patients 
requiring increased social support 
o 4 = Exceeds expectations in evaluation of social support using MOS-SSS and 
applies results to surgical risk assessment 
Cognitive Impairment 
o 0 = Did Not Assess 
o 1 = Minimal understanding of the MMSE and does not accurately evaluate patient 
o 2 = Partial mastery of the MMSE but does not accurately identify patients with 
cognitive impairment 
o 3 = Proficient mastery of the MMSE and accurately identifies patients with 
cognitive impairment 
o 4 = Exceeds expectations of cognitive impairment using the MMSE and applies 
results to surgical risk assessment 
Depression 
o 0 = Did Not Assess 
o 1 = Minimal understanding of the GDS and does not accurately evaluate patient 
o 2 = Partial mastery of the GDS but does not accurately identify patients at risk for 
depression 
o 3 = Proficient mastery of the GDS and accurately identifies patients at risk for 
depression 
o 4 = Exceeds expectations of depression screening using the GDS and applies 
results to surgical risk assessment 
Score: _____ 
Does the observer believe the student needs to remediate this SOCS?     YES     NO 
Student Signature __________________  Observer Signature ___________________ 
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LIST OF JOURNAL ABBREVIATIONS 
AJPH American Journal of Public Health 
Ann Oncol Annals of Oncology 
Ann Surg Oncol Annals of Surgical Oncology 
Arch Intern Med Archives of Internal Medicine  
BMJ British Medical Journal 
Clin Geriatr Med Clinics in Geriatric Medicine 
Clin Interv Aging Journal of Clinical Interventions in Aging 
Clin Nutr Clinical Nutrition 
CMAJ Canadian Medical Association Journal 
CROH Critical Reviews in Oncology/Hematology 
EJC European Journal of Cancer 
EJSO European Journal of Surgical Oncology 
I J Epidemiol International Journal of Epidemiology 
J Am Coll Surg Journal of the American College of Surgeons 
J Geriatr Oncol Journal of Geriatric Oncology 
J Gerontol A Biol Sci 
Med Sci 
Journals of Gerontology Series A: Biological Sciences and 
Medical Sciences 
J Nutr Health Aging The Journal of Nutrition, Health, & Aging 
J Oncol Manag The Journal of Oncology Management 
J Psychiatr Res Journal of Psychiatric Research 
J Surg Oncol Journal of Surgical Oncology 
JAMA Oncol The Journal of the American Medical Association Oncology 
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JCO Journal of Clincal Oncology 
JNCI Journal of the National Cancer Institute 
Mayo Clin Proc Mayo Clinic Proceedings  
NEJM New England Journal of Medicine  
Res Nurs Health Research in Nursing & Health 
Semin Oncol Nurs Seminars in Oncology Nursing 
TJ Tumori Journal 
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